Investigating the generalisation of an atlas-based synthetic-CT algorithm to another centre and MR scanner for prostate MR-only radiotherapy by Wyatt, JJ et al.
This is a repository copy of Investigating the generalisation of an atlas-based synthetic-CT
algorithm to another centre and MR scanner for prostate MR-only radiotherapy.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/124569/
Version: Accepted Version
Article:
Wyatt, JJ, Dowling, JA, Kelly, CG et al. (6 more authors) (2017) Investigating the 
generalisation of an atlas-based synthetic-CT algorithm to another centre and MR scanner
for prostate MR-only radiotherapy. Physics in Medicine and Biology, 62 (24). N548-N560. 
ISSN 0031-9155 
https://doi.org/10.1088/1361-6560/aa9676
(c) 2017, Institute of Physics and Engineering in Medicine. This is an author-created, 
un-copyedited version of an article published Physics in Medicine and Biology. IOP 
Publishing Ltd is not responsible for any errors or omissions in this version of the 
manuscript or any version derived from it. The Version of Record is available online at: 
https://doi.org/10.1088/1361-6560/aa9676 
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
Items deposited in White Rose Research Online are protected by copyright, with all rights reserved unless 
indicated otherwise. They may be downloaded and/or printed for private study, or other acts as permitted by 
national copyright laws. The publisher or other rights holders may allow further reproduction and re-use of 
the full text version. This is indicated by the licence information on the White Rose Research Online record 
for the item. 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
Investigating the generalisation of an atlas-based
synthetic-CT algorithm to another centre and MR
scanner for prostate MR-only radiotherapy
Jonathan J. Wyatt1, Jason A. Dowling2, Charles G. Kelly1, Jill
McKenna1, Emily Johnstone3, Richard Speight4, Ann Henry3,4,
Peter B. Greer5, Hazel M. McCallum1
1 Northern Centre for Cancer Care, Newcastle upon Tyne Hospitals, UK
2 CSIRO Australian e-Health Research Centre, Australia
3 Leeds Institute of Cancer and Pathology, University of Leeds, UK
4 Leeds Cancer Centre, Leeds Teaching Hospitals, UK
5 Calvary Mater Newcastle Hospital, Australia
E-mail: jonathanwyatt@nhs.net
Abstract.
There is increasing interest in MR-only radiotherapy planning since it provides
superb soft-tissue contrast without the registration uncertainties inherent in a CT-
MR registration. However MR images cannot readily provide the electron density
information necessary for radiotherapy dose calculation. An algorithm which generates
synthetic CT’s for dose calculations from MR images of the prostate using an atlas of
3 T MR images has been previously reported by two of the authors. This paper aimed
to evaluate this algorithm using MR data acquired at a different field strength and a
different centre to the algorithm atlas. 21 prostate patients received planning 1.5 T
MR and CT scans with routine immobilisation devices on a flat-top couch set-up using
external lasers. The MR receive coils were supported by a coil bridge. Synthetic CT’s
were generated from the planning MR images with (sCT1V) and without (sCT) a one
voxel body contour expansion included in the algorithm. This was to test whether this
expansion was required for 1.5 T images. Both synthetic CT’s were rigidly registered
to the planning CT (pCT). A 6 MV Volumetric Modulated Arc Therapy plan was
created on the pCT and recalculated on the sCT and sCT1V. The synthetic CT’s dose
distributions were compared to the dose distribution calculated on the pCT.
The percentage dose difference at isocentre without the body contour expansion
(sCT - pCT) was ∆DsCT = (0.9 ± 0.8)% and with (sCT1V - pCT) was ∆DsCT1V =
(−0.7 ± 0.7)% (mean ± one standard deviation). The sCT1V result was within one
standard deviation of zero and agreed with the result reported previously using 3 T
MR data. The sCT dose difference only agreed within two standard deviations. The
mean ± one standard deviation gamma pass rate was ΓsCT = 96.1 ± 2.9% for the
sCT and ΓsCT1V = 98.8 ± 0.5% for the sCT1V (with 2% global dose difference and
2 mm distance to agreement gamma criteria). The one voxel body contour expansion
improves the synthetic CT accuracy for MR images acquired at 1.5 T but requires the
MR voxel size to be similar to the atlas MR voxel size. This study suggests that the
atlas-based algorithm can be generalised to MR data acquired using a different field
strength at a different centre.
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1. Introduction
The use of Magnetic Resonance (MR) images to delineate the prostate for radiotherapy
treatment planning has expanded significantly due to the superb soft-tissue contrast
of MR (Khoo & Joon 2006). This has resulted in reduced intra- and inter-observer
variability of prostate contours compared to CT (Dubois et al. 1998) and a reduced
overall prostate volume (Dubois et al. 1998, Rasch et al. 1999). Typically MR images
are registered with a planning Computed Tomography (CT), with the MR used for
contour delineation and the CT for radiotherapy planning and dose calculations. This
is because the MR signal intensity depends on proton spins, which means that both
air and bone will have near zero signal intensities despite having very different electron
densities. Therefore MR images cannot be directly calibrated to relate to electron
density for radiotherapy dose calculations. Unfortunately the MR-CT registration in
prostate radiotherapy treatments can be sub-optimal due to differences in bladder and
rectum filling between the two imaging sessions, despite using a bladder and bowel
preparation protocol. This results in a significant delineation uncertainty arising from
the registration (Nyholm et al. 2009). This uncertainty can be removed by utilising a
MR-only planning approach which eliminates the need for a planning CT.
MR-only planning requires a method of providing an electron density map for
radiotherapy dose calculations. The most common method is to generate a synthetic
CT (sCT) from the MR that can then be used to replace the conventional CT in the
radiotherapy planning process. Three main approaches have been adopted for the
prostate clinical site: bulk density assignments, regression-based methods and atlas-
based methods, with the latter two being the most clinically appropriate (Johnstone
et al. 2017). The attraction of atlas-based methods is that they do not require any
specialist MR sequences, although they do require dedicated MR acquisition protocols
which are optimised for geometric accuracy over the whole field of view (Paulson
et al. 2015). Several groups have developed automatic or semi-automatic atlas-based
methods of generating a sCT for prostate radiotherapy (Dowling et al. 2015, Siversson
et al. 2015, Chen et al. 2016), which use an atlas of co-registered CT-MR pairs and
deformable registration techniques to generate a sCT. Each of these algorithms use an
atlas created from data acquired on the same MR scanner, at the same field strength.
In addition both Dowling et al. and Chen et al. evaluated their methods using a ‘ leave
one out’ approach where one of the atlas pairs is used as the subject and remaining
pairs used as the atlas.
For these algorithms to be applicable within a routine clinical setting it is important
to evaluate them using data different to the atlas data. This is because the performance
of an atlas-based algorithm depends on the registration quality between the incoming
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image and the atlas (Despotovic´ et al. 2015). The quality of the registration in turn
depends on the similarity of the incoming MR image to the atlas images. MR images
can vary substantially depending on the scanner, acquisition sequence and patient
(Nyu´l et al. 1999). There can still be significant variations between different scanners
and vendors even when using the same sequence and acquisition parameters (Bauer
et al. 2010). These image variations can influence the performance of segmentation
algorithms (Udupa et al. 2006). Small differences in acquisition parameters can also
change the contrast in the images (Fischl et al. 2004) and the accuracy of atlas-based
segmentation algorithms often reduces when images with different contrasts to the atlas
images are used (Han & Fischl 2007). In particular MR images acquired at a different
field strength to the atlas images can have significantly different signal to noise and
contrast to noise ratios (Soher et al. 2007) as well as increased magnetic susceptibility
effects and image intensity non-uniformities (Chow et al. 2015). Jovicich et al. found
that changing the field strength changed the results of an atlas-based segmentation
algorithm for the brain (Jovicich et al. 2009). Similarly Chow et al. found some
significant differences in atlas-based segmented volumes of the brain in the same subjects
at 1.5 T and 3 T (Chow et al. 2015). Images acquired at different field strengths
will also differ due to chemical shift and Gibb’s (signal truncation) artefacts (Dietrich
et al. 2008). All of these image variations mean data acquired on different scanners to
those in the atlas could result in sub-optimal registrations to the atlas MR’s and so
adversely impact the quality of the synthetic CT produced. Therefore it is important
to validate atlas-based sCT algorithms using different data to those in the atlas, and
in particular acquired at a different field strength. This study aimed to investigate
the generalisation of the Dowling algorithm by evaluating it using data acquired at a
different field strength with a different MR scanner in a different centre.
2. Methods
2.1. Patient Data Collection
This was a retrospective study involving prostate radiotherapy patients at the Northern
Centre for Cancer Care. Patients were selected from two time periods (01/12/2015 -
13/01/2016 and 12/05/2016 - 22/06/2016). The following exclusion criteria were applied
(number of patients excluded): hip prostheses (2), post-prostatectomy (0), the patient
external contour was larger than the maximum MR field of view (13) and gross patient
motion artefact (1). Gross patient motion artefact was determined qualitatively and
defined by significant blurring and ghosting in the phase encode direction. 21 patients
were included in this study with an inclusion rate of 54%. Patients were aged between
54 and 79 years, with the median age being 70 years. All patients had been diagnosed
with prostate cancer (stages T1 to T3). Each patient received a planning MR (1.5 T
Magnetom Espree, Siemens, Erlangen, Germany) and CT (Sensation Open, Siemens,
Erlangen, Germany) scan as part of the routine radiotherapy planning procedure. All
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patient scans were anonymised prior to being included in the study.
Both CT and MR scans were performed on flat couch tops with the patients in the
local standard prostate radiotherapy immobilisation. All patients underwent routine
bladder and bowel preparation prior to each scan. The bladder preparation protocol
consisted of an empty bladder 30 minutes prior to the scan, followed by drinking 400 ml
of water. The bowel preparation protocol required application of a micro-enema 45
minutes prior to the scan followed by bowel emptying. Internal fiducial markers were
not present in any patient. To avoid distorting the external patient contour the MR
images were acquired using a 6 channel flexible receive coil (Siemens Body Matrix)
supported over the patient by an in-house manufactured coil bridge and the 24 channel
spine receive coil contained in the couch (Siemens Spine Matrix).
The MR images were acquired using the same pulse sequence and similar acquisition
parameters as used in Dowling et al. (Dowling et al. 2015). The acquisition parameters
in this study were not identical to those used in Dowling et al. as the data in this
study was acquired as part of the routine planning MR scan and used retrospectively.
The MR images in this study were acquired with a T2-weighted SPACE (Sampling
Perfection with Application optimised Contrasts using different flip angle Evolution)
sequence. This is a 3D turbo spin echo sequence with a repetition time TR = 1500 ms,
an echo time TE = 210 ms and a constant flip angle α = 150o. The echo train length
was 85 with an echo spacing of 3.82 ms. The Field of View (FoV) was 450 × 450 mm2
for all patients, encompassing the entire patient external contour, with a voxel size
1.8 × 1.8 × 1.7 mm3. 120 slices were acquired giving a longitudinal scan length of
204 mm for all patients. The receive bandwidth was large, ∆f = 592 Hz · [pixel]−1
and the Siemens 3D distortion correction algorithm was applied to reduce the geometric
distortion in the images. The main differences to the parameters used by Dowling et
al. were the resolution of the 3 T atlas images (voxel size 1.6× 1.6× 1.6 mm3) and the
T1-weighting (repetition time TR = 1200 ms and flip angle α = 135o). The echo time
of the atlas images (TE = 97 ms) was approximately half the echo time used in this
study. The CT images were acquired in this study with a voxel size of 1.1× 1.1× 3 mm
and a tube voltage of V = 120 kVp. A representative planning CT and MR are shown
in figure 1.
2.2. Synthetic CT Generation
The sCT’s were generated using the Dowling algorithm as described previously (Dowling
et al. 2015). The algorithm is briefly summarised here for convenience:
(i) The atlas consisted of 39 CT-MR pairs acquired on a 3 T MR scanner (Skyra,
Siemens) and one of two CT scanners (LightSpeedRT, GE Healthcare, Wisconsin,
USA and Aquilion, Toshiba, Tokyo, Japan). Each MR image was preprocessed
through bias field correction, histogram equalisation and smoothing via gradient
anisotropic diffusion. Each atlas CT was registered to the atlas MR using a robust
rigid registration followed by a structure guided deformable registration.
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(a) Planning CT (b) Planning MR
Figure 1: An example of the planning CT (a) and MR (b). The MR is taken in the treatment
position on a flat top couch and with the receive coils supported above the patient surface.
(ii) The incoming MR is preprocessed as described in step (i). Each atlas MR was
registered to the incoming MR using the same robust rigid registration as above,
followed by a deformable registration (not structure-guided).
(iii) These deformation fields are applied to each corresponding atlas CT.
(iv) The deformed atlas CT’s are combined together to create a sCT using local voting.
This compares a small patch (radius two voxels) around each voxel in the incoming
MR with the equivalent patch in each of the registered atlas MR’s. The normalised
sum of squared differences is computed for each atlas MR, which are used to weight
the contribution to each sCT voxel from the corresponding atlas CT.
(v) The external body contour of the sCT is grown isotropically by one voxel using
a nearest neighbour interpolation. This accounted for an observed systematic
difference in body shape between the MR and CT. The contour expansion was
assigned a uniform value of 47 HU, based on the average value of the outer 1 mm
of the skin layer in planning CT images of the pelvis.
The parameters used within the local weighted voting component of the algorithm
were a patch radius of 2 voxels and a gain of 1, matching those used in Dowling et
al. In the Dowling algorithm the body contour expansion was added to account for an
observed systematic difference in body contour between the 3 T T2-weighted MR images
and the CT images. This was hypothesised to be due to MR signal loss in the outer
skin layer (Dowling et al. 2015). It has not been established whether this expansion was
required at 1.5 T. Therefore in this study two sets of sCT images were created, one with
the one voxel body contour expansion as described in Dowling et al. (sCT1V) and one
without the contour expansion (sCT), omitting step 5. above (see figure 2).
2.3. Evaluation
The planning CT (pCT) was registered to both the sCT and sCT1V using RayStation’s
(version 5, RaySearch Laboratories, Stockholm, Sweden) automatic intensity-based
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Synthetic CT Planning CT
HU Mass Density/g · cm−3 HU Mass Density/g · cm−3
-1000 0.0001 -971 0.001
-791 0.2 -710.2 0.3
-506 0.5 -569.6 0.45
-26 0.99 -89.7 0.92
-1 1 -2.7 1.015
45.5 1.06 83.5 1.08
53.5 1.07 166 1.17
231 1.16 440.1 1.34
992 1.61 784.6 1.56
3403 2.87 1178.2 1.84
Table 1: The HU - mass density calibration curves used for the synthetic CT’s and planning
CT.
mutual information rigid registration algorithm. The two registrations (pCT to sCT
and pCT to sCT1V) were carried out independently. This ensured each synthetic CT
was optimally registered to the pCT, but resulted in the two registrations being slightly
different. This difference was quantified by calculating the mean of the differences in
each translation and rotation axis.
RayStation enables multiple Hounsfield Unit (HU) - mass density calibration curves
to be used. Therefore two different curves were used in this study, one to calibrate each
pCT and one to calibrate the synthetic CT’s. The two curves used are given in table
1. The pCT curve used was the clincal HU - mass density calibration curve for the
local CT scanner. The synthetic CT’s are produced from a combination of the atlas
CT’s. Therefore the appropriate HU calibration curve to use is the curve for the CT’s
contained in the atlas. The Dowling algorithm includes atlas patients from two different
CT scanners with two different HU - mass density calibration curves. Therefore a
composite curve of the unweighted average of the two curves was used for the synthetic
CT’s. This could introduce a small confounding dose error if a particular synthetic CT
was heavily weighted towards atlas CT scans from only one of the CT scanners. To
estimate this error a treatment plan was recalculated three times on one patient sCT:
once with each of the atlas scanner calibration curves and once with mean curve that
was used in the evaluation. The dose difference at isocentre with each calibration curve
was calculated.
The external contour was automatically outlined on each dataset with a Hounsfield
Unit threshold of T = −250 HU. The external contours of the sCT and sCT1V were
compared to the planning CT external contour using the Dice similarity coefficient
(DSC), mean and maximum distance to agreement (DTAmean and DTAmax), which
were calculated using RayStation.
After the image registration was carried out the clinical structure set was copied
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from the pCT onto both the sCT and sCT1V using the relevant registration matrix. The
structure set was based on the CHHiP trial with three Planning Target Volumes (PTV)
(Dearnaley et al. 2016). The clinical structure set was not modified after transfer and
was used to enable dose volume histogram points of the central PTV (PTV3) to be
compared. The automatically generated contours produced by the Dowling algorithm
were not evaluated in this study.
A 6 MV Volumetric Modulated Arc Therapy (VMAT) plan was created on the pCT.
The local clinical plan protocol was used, consisting of a single 360o arc plan with a 5
degree collimator rotation and a prescription of 60 Gy in 20 fractions to 50% of PTV3.
The local class solution was applied and the plan optimised until the difference in cost
function between consecutive iterations fell below a set threshold or when 40 iterations
was reached, whichever occurred first. A final dose calculation was then performed on
the optimised plan with a 2×2×2 mm3 dose grid. The treatment plan was recalculated
on both the sCT and sCT1V keeping the monitor units and the dose grid voxel size and
position the same. The percentage difference in isocentre dose between each synthetic
CT and the pCT was calculated using
∆DHUsCT = 100
DsCT −DpCT
DpCT
, (1)
whereDsCT was the dose at the isocentre for the sCT,DpCT was the dose at the isocentre
for the pCT and HU indicates that a Hounsfields Units (HU) based density correction
was used in the dose calculation. An equivalent equation was used for the dose difference
between sCT1V and the pCT, ∆D
HU
sCT1V
. The percentage doses differences for the PTV3
Dose Volume Histogram (DVH) points D98, D95, D50, D5 and D2 were also calculated
for both sCT and sCT1V using the same method.
A gamma analysis was performed comparing the dose calculated on the pCT
to the dose calculated on the sCT and sCT1V. The gamma analysis was calculated
using the SlicerRT toolkit within the open-source 3D Slicer application (version 4.6.2,
www.slicer.org) (Fedorov et al. 2012, Pinter et al. 2012). A 3D global gamma analysis
was carried out with the following criteria: dose difference 1% of prescription dose (60
Gy) and distance to agreement 1 mm , dose difference 1% and distance to agreement
2 mm and dose difference 2% and distance to agreement 2 mm. The gamma analysis was
carried out within the external contour only and with all dose points below a threshold
of 10% of the prescription dose (60 Gy) excluded.
In order to determine the effect of inter-scan body contour differences between pCT
and synthetic CT’s due to the scans being acquired in separate imaging sessions, the
density for each image dataset was over-ridden and set to unity, ρ = 1 g · cm−3 (i.e.
water). The treatment plan was recalculated on all three image datasets, keeping the
monitor units and the dose grid constant. Therefore the only difference between the
synthetic CT’s and the pCT was the external contour. The percentage dose differences
in isocentre dose and the five PTV3 DVH points defined earlier were calculated.
Finally the radiological water equivalent isocentre depth for the VMAT plan was
calculated at 4o angles for each image in the plane of the isocentre, following Siversson
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Image Density % Dose Difference
D98 D95 D50 D5 D2
sCT HU 1.0 (3.2) 1.0 (3.1) 1.0 (2.9) 1.1 (3.2) 1.1 (3.4)
sCT Water 1.2 (2.4) 1.2 (2.4) 1.1 (2.2) 1.1 (2.3) 1.1 (2.4)
sCT1V HU −0.7 (−2.2) −0.7 (−2.2) −0.7 (−1.7) −0.7 (−1.4) −0.7 (−1.6)
sCT1V Water −0.5 (−1.3) −0.6 (−1.3) −0.6 (−1.3) −0.6 (−1.4) −0.6 (−1.3)
Table 2: The mean (maximum) percentage dose differences (synthetic CT minus planning CT
as a percentage of the planning CT) at different PTV3 DVH points for both synthetic CT’s
for all patients (n=21). The density indicates the density correction used within the dose
calculation (HU = Hounsfield Units, Water = 1 g · cm−3).
et al. (Siversson et al. 2015). This radiological equivalent depth was calculated by
RayStation using the HU value of each voxel and the relevant HU - electron density
curve (table 1). The physical isocentre depth for each angle was also calculated. The
mean difference in equivalent and physical isocentre depth between each synthetic CT
and the pCT for each patient was calculated.
3. Results
The percentage dose difference at the isocentre between the pCT and the sCT
and sCT1V respectively was ∆D
HU
sCT = 0.9 ± 0.8 (−0.5, 2.9) % and ∆D
HU
sCT1V
=
−0.7 ± 0.7 (−2.1, 0.9) %, results given as mean ± one standard deviation (minimum,
maximum). The equivalent results using the water density correction in the calculation
were within 0.2 %, ∆DWsCT = 1.1 ± 0.5 (0.1, 2.3) % and ∆D
W
sCT1V
= −0.6 ±
0.5 (−1.2, 0.4) %. The percentage differences at a range of PTV3 DVH points are
given in table 2. An example dose distribution on the planning CT and both synthetic
CT’s for a typical patient is shown in figure 2. The dose difference maps for the sCT
and sCT1V for the same patient are shown in figure 3.
The maximum error arising from using a composite HU-mass density calibration
for the synthetic CT’s was a 0.1 % dose difference at the isocentre. This was true for
both the sCT and sCT1V.
The results of the comparison between the external contours on the pCT and
synthetic CT’s are shown in table 3. The mean results for the sCT1V were closer to the
pCT external contour than the sCT for each metric. However the differences were small
and agreed within one standard deviation.
The differences between the two registrations (pCT to sCT and pCT to sCT1V) were
small. The mean translation difference in the inferior-superior direction (the largest)
was ∆t = 0.17± 0.18 cm (± one standard deviation) and the mean rotational difference
in the pitch direction (the largest) was ∆r = 0.13± 0.55o.
The mean difference in equivalent isocentre depth for the sCT was ∆zequivsCT =
−2.1 ± 1.9 (−6.2, 2.7) mm and for the sCT1V ∆z
equiv
sCT1V
= 1.6 ± 1.9 (−2.4, 6.4) mm,
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(a) pCT (b) sCT
(c) sCT1V
Figure 2: An example dose distribution on the pCT (a), sCT (b) and sCT1V (c). Isodoses
are shown as percentages of the prescription dose (60 Gy). The isocentre dose differences for
this patient were ∆DHUsCT = 1.2 % and ∆D
HU
sCT1V
= −0.4 %. The gamma pass rates were
ΓsCT = 93.9 % and ΓsCT1V = 99.4 %.
Metric sCT sCT1V
DSC 0.94± 0.02 (0.87, 0.97) 0.95± 0.03 (0.88, 0.98)
DTAmean /cm 0.45± 0.19 (0.26, 1.16) 0.42± 0.22 (0.22, 1.10)
DTAmax /cm 2.62± 0.80 (1.58, 4.50) 2.25± 0.81 (1.21, 4.40)
Table 3: The mean ± standard deviation (minimum, maximum) result for each comparison
metric comparing the external contour of the synthetic CT to the pCT. DSC is the dice
similarity coefficient, DTAmean is the mean distance to agreement and DTAmax the maximum
distance to agreement. DSC is a dimensionless comparison metric and the two distance to
agreement metrics are given in cm.
results given as mean ± one standard deviation (mininum, maximum). The mean
difference in physical isocentre depth was ∆zphyssCT = −2.6 ± 1.1 (−4.9,−1.0) mm and
∆zphyssCT1V = 1.2± 1.1 (−1.2, 2.7) mm for the sCT and sCT1V respectively.
The gamma analysis pass rates are given in table 4. Figure 4 gives example gamma
maps for the same patient shown in figure 2.
4. Discussion
The aim of this study was to evaluate an atlas-based synthetic CT algorithm using MR
data acquired at a different field strength and centre. The algorithm was evaluated with
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(a) sCT (HU) (b) sCT1V (HU)
(c) sCT (Water) (d) sCT1V (Water)
Figure 3: The dose difference maps for the sCT (a) and sCT1V (b) calculated using the HU
density correction for the same patient shown in figure 2. The equivalent dose difference maps
calculated with the density set to unity for the pCT and the sCT (c) and sCT1V (d). Dose
differences are shown as a percentage of the prescription dose (60 Gy).
Image Gamma Pass Rate/%
1%/1 mm 1%/2 mm 2%/2 mm
sCT 91.1± 7.0 (72.2, 97.1) 92.6± 6.0 (76.6, 97.7) 96.1± 2.9 (88.2, 98.6)
sCT1V 95.2± 2.9 (88.3, 98.5) 96.0± 2.3 (90.7, 98.7) 98.8± 0.5 (97.6, 99.5)
Table 4: The mean ± standard deviation (minimum, maximum) gamma pass rates for the
sCT and sCT1V over the whole study population. The pass rates are shown for the three
different gamma criteria.
and without a one voxel body contour expansion to determine if this was necessary at
1.5 T.
Our results appear to show that the one voxel body contour expansion is required
at 1.5 T. This can be seen dosimetrically with the mean isocentre dose differences
from the pCT and all the PTV3 DVH points being smaller, and the gamma pass rates
higher, for the sCT1V compared to the sCT. In addition, geometrically the differences
in equivalent and physical isocentre depth with the sCT1V were closer to zero than for
the sCT. The change in physical isocentre depth difference for the sCT and sCT1V was
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(a) sCT (b) sCT1V
Figure 4: Example gamma map for the sCT (left) and sCT1V (right) for the same patient
shown in figure 2. Gamma criteria were 1% global dose difference and 1 mm distance to
agreement.
3.8 mm, significantly larger than 1.8 mm voxel expansion expected. This is primarily
due to the nearest neighbour interpolation method used to produce the body contour
expansion, which results in larger than one voxel expansions in areas where the body
contour is curved. This 3.8 mm mean difference in isocentre depth is consistent with
the observed dose difference at isocentre between sCT and sCT1V of 1.7%. Finally the
sCT1V external contour agreed better with pCT external contour on the comparison
metrics investigated, although the differences were small and insignificant. There is an
apparent discrepancy between the mean distance to agreement metric and the physical
isocentre depth difference. This is likely to be due to the distance to agreement metric
including the differences between the pCT and synthetic CT’s in the superior and inferior
directions, as well as axially.
The sCT1V seems to over-correct the systematic difference in body contour
expansion, with only two patients (10%) having a negative physical isocentre depth
difference. This may be due to the MR images in this study having a larger voxel size
than used in Dowling et al, which would produce a larger expansion. This indicates a
limitation to the generalisation of this algorithm since it will depend on the voxel size of
the MR images, with the algorithm requiring the voxel size to be ‘similar’ to that found
in the atlas. Further work would be required to investigate how sensitive the algorithm
is to differences in MR voxel size.
There will be small differences in body contour shape between the pCT and planning
MR (and therefore the synthetic CT’s) because the scans were acquired in separate
imaging sessions (Maspero et al. 2017). These inter-scan differences will introduce a
confounding error into the dosimetric evaluation by generating dosimetric differences
that are not due to errors in the Hounsfield Units within the synthetic CT’s but in the
differences in body contour shape to the pCT. The dose differences calculated with the
densities of the synthetic CT’s and the pCT over-ridden to water indicate the magnitude
of the dose differences caused by these inter-scan differences. The water calculated
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isocentre dose differences were within 0.2 % to those measured with Hounsfield Units
and appeared very similar (see figure 3). This suggests that a significant contribution
to the observed dose differences are due to inter-scan differences in body contour, rather
than errors in Hounsfield Unit assignment.
The mean isocentre dose difference to the sCT1V in this study agreed within
one standard deviation of the result reported by Dowling et al., ∆D = −0.3 ±
0.8 (−1.5, 1.8) % (Dowling et al. 2015). Similarly the sCT1V mean dose differences
for the DVH points evaluated all agreed within one standard deviation and the median
gamma pass rates agreed within 3% with those presented in Dowling et al. This suggests
that the Dowling algorithm with body contour expansion is generalisable to 1.5 T data
acquired at a different centre with a similar MR voxel size.
This is an important result because it demonstrates that the preprocessing steps
contained in the algorithm are able to mitigate the image intensity differences between
MR images acquired on different scanners sufficiently to not degrade the image
registration quality (Despotovic´ et al. 2015). This result also suggests that the algorithm
is robust to the differences in contrast between images acquired with the same sequence
and similar, but not identical, acquisition parameters (Han & Fischl 2007). In particular
this study demonstrates that the algorithm can be used for images acquired at a different
field strength to the atlas. This is in contrast to the results found for automatically
segmented brain volumes using an atlas-based segmentation algorithm on 1.5 T and 3
T images (Jovicich et al. 2009, Chow et al. 2015). This may be because the effect of
interest in this case, the calculated dose distribution, is less sensitive to small changes in
synthetic CT and so the algorithm overall is less sensitive to changes in field strength.
Susceptibility effects and chemical shift artefacts will be different at 1.5 T and 3 T, but
were minimised in both sets of images by having large acquisition bandwidths (Soher
et al. 2007). The chemical shift was ∼ 0.6 pixels for the 3 T images and ∼ 0.4 pixels
for the 1.5 T images and therefore likely to have had a negligible impact on the image
registration within the Dowling algorithm. Changing the field strength will also result
in differences in Gibbs artefacts (Dietrich et al. 2008). However both sets of images had
similar voxel sizes and good signal to noise ratios and so differences in Gibbs artefacts
were also likely to minimally impact the registration quality. This may be another
reason why the algorithm may not generalise very well for MR images acquired with
significantly different voxel sizes.
This study has demonstrated that this algorithm will generalise to data acquired
using a different scanner at a different field strength with the same sequence and similar
acquisition parameters, notably a sufficiently high bandwidth and similar voxel size.
These features are recommended for MR images acquired for radiotherapy planning to
reduce geometric distortion and provide sufficient resolution for accurate contouring
(Liney & Moerland 2014). Further work on evaluating the generalisation of this
algorithm could include investigating data acquired with different vendor scanners and
with larger differences in acquisition parameters.
The results from this study are similar to those reported in the literature for
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other atlas-based methods of synthetic CT generation for the prostate. Siversson et
al. reported a mean dose difference in the PTV D50 of ∆D50 = 0.1 ± 0.4% (mean ±
one standard deviation) when evaluated using data acquired at the same scanner as the
atlas data and ∆D50 = 0.6± 0.5% using data acquired at a different scanner (Siversson
et al. 2015). The authors did not specify how the dose difference was calculated so
only the magnitude and not the sign of the dose difference can be compared to the
results in this study. Chen et al. reported PTV D95 differences of ∆D95 = 0.1± 0.1%
(mean ± one standard deviation) (Chen et al. 2016). However the dose differences
were evaluated after the sCT was deformably registered to the evaluation planning CT,
thus ensuring the outer body contours were identical. This would remove a significant
source of differences between the sCT and pCT, and therefore reduce the observed dose
difference.
The results of this study compare favourably with other methods of sCT generation
for the prostate. Lambert et al. used a bulk density method and found a isocentre
dose difference of ∆Diso = −1.3 ± 0.8% (mean ± one standard deviation) (Lambert
et al. 2011). Korhonen et al. used a dual model regression based technique and reported
PTV D50 dose difference of ∆D50 = 0.3 ± 0.2% (mean ± one standard deviation)
(Korhonen et al. 2014). Kim et al. also used a regression based technique and found
a mean PTV D95 dose difference of ∆D95 = 0.3%. A significant advantage of the
atlas-based algorithm evaluated here is that it was automatic, which eliminates time
consuming manual contouring.
5. Conclusion
This study has demonstrated that a 3 T atlas-based synthetic CT algorithm can be used
on 1.5 T data acquired at a different centre using a similar MR acquisition protocol. The
mean dose differences to the planning target volume were less than 1% and within one
standard deviation of 0% difference. The one voxel body contour expansion contained
in the Dowling algorithm improves the accuracy of the result compared to synthetic
CT’s without the expansion. This expansion step requires MR voxel sizes which are
similar to those contained in the Dowling atlas, which limits the generalisation of the
algorithm. Further work is needed to determine how close the voxel size needs to be
in order to give accurate results. The algorithm only requires widely available, routine
MR sequences and the entire process of synthetic CT generation is automatic. Further
work is required to investigate the accuracy of synthetic CT’s in on-treatment image
verification using Cone Beam CT. The Dowling algorithm appears a good candidate for
use within a clinical MR-only planning prostate radiotherapy workflow.
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